You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: P39 Mutational landscape of 109 MDS and 64 AML patients: a single-centre study

€3.03

SKU: product-article-15313 Category: General

Description
Reviews (0)

Description

P39 Mutational landscape of 109 MDS and 64 AML patients: a single-centre study

Reviews

There are no reviews yet.

Be the first to review “Article: P39 Mutational landscape of 109 MDS and 64 AML patients: a single-centre study”

You must be logged in to post a review.

Top

Article: P39 Mutational landscape of 109 MDS and 64 AML patients: a single-centre study

Description

Reviews

Related products

Article: Highlights in breast cancer

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in gynaecological cancers

Article: Calendar of events